The IDSA Center for Global Health Policy and the HIV Medicine Association released a policy statement on the results of HPTN 052 with recommendations for U.S. global and domestic AIDS Policy. Entitled “U.S. Policy and Funding on AIDS Should Follow the Science,” the statement recommends that a larger share of the PEPFAR budget be devoted […]
The following is a blog post by Kristen Jill Kresge of the International AIDS Vaccine Initiative. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Kresge provides a synopsis of the first plenary session of the conference. The post was originally published on IAVIReport. At the first plenary session of AIDS Vaccine 2011, which opened this […]
The following is a blog post by Jose Esparza, Deputy Director of HIV Vaccines at the Bill and Melinda Gates Foundation. Writing from the AIDS Vaccine Conference in Bangkok, Thailand, Dr. Esparza discusses recent scientific developments in the creation of an AIDS vaccine, and what we can expect to see in the future. The post […]
HIV
To control the global health threat of HIV by 2030, according to UNAIDS, these goals must be reached by 2020: To diagnose 90 percent of all […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With more than 112,000 cases of measles reported by 170 countries so far this year, the world is seeing rising rates of a vaccine-preventable illness over […]